Robert J Guttendorf is an accomplished inventor based in Gaithersburg, MD, with a focus on enhancing the efficacy of antibiotics. He holds two patents that reflect his commitment to improving medical treatments and patient outcomes.

Latest Patents

Guttendorf's latest patents include "Compositions and methods for improved efficacy of penicillin-type antibiotics." This patent discloses once-a-day penicillin-type antibiotic products that comprise at least one modified release dosage form. These products are designed to provide T>MIC in the serum for at least five consecutive hours within a 24-hour dosing interval, ensuring effective treatment against specific bacterial pathogens. Another significant patent is "Pharmaceutical compositions and methods for improved bacterial eradication." This process involves administering a modified release dosage form containing an antibiotic to treat bacterial infections effectively.

Career Highlights

Throughout his career, Guttendorf has made significant contributions to the field of pharmaceuticals. His work has focused on developing innovative solutions that address the challenges of antibiotic efficacy and bacterial resistance. His patents demonstrate a deep understanding of pharmacology and a commitment to advancing medical science.

Collaborations

Guttendorf has collaborated with notable colleagues, including Henry H Flanner and Susan P Clausen. These partnerships have likely contributed to the success of his innovative projects and patents.

Conclusion

Robert J Guttendorf's contributions to antibiotic development highlight his role as a key innovator in the pharmaceutical industry. His patents reflect a dedication to improving healthcare and patient treatment options.